European Journal of Paediatric Neurology

Papers
(The TQCC of European Journal of Paediatric Neurology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial90
Urgent unmet need for pharmaceutical grade vitamin therapy in pyridoxine dependent epilepsies47
‘Focal Seizures in Dystonic Cerebral Palsy (DCP): Rare or common or both?40
Analysis of the relation between cerebrospinal fluid antibody titers and clinical characteristics in pediatric patients with anti-N-methyl-D-aspartate receptor encephalitis30
CSF IL-6 in pediatric neuroinflammation: Diagnosing disease or driving therapy?27
Associations between muscle morphology and spasticity in children with spastic cerebral palsy26
The utility of creatine kinase in status dystonicus and pre-status dystonicus26
A life course perspective on mental disorders and psychopharmacologic drug use among persons living with cerebral palsy25
Autoimmune encephalitis in Israeli children – A retrospective nationwide study24
Spinal cord stimulation (SCS) induced favorable neuromodulative outcome in the treatment of chronic neuropathic pain syndrome in children24
Pediatric varicella zoster virus associated arterial ischemic stroke – A post-pandemic rise in incidence in Denmark24
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review20
Treatment response in children with relapsing MOG-antibody associated disease20
Motor imagery ability of children with duchenne muscular dystrophy: Reliability and validity of kinesthetic and Visual Imagery Questionnaire-10, and its association with cognitive status20
Is late diagnosis of Duchenne muscular dystrophy still a reality?19
Disruptive lesions can cause developmental anomalies in the fetal brain: Mini-review19
Clinical presentation, MR imaging and outcome in children with myelin oligodendrocyte glycoprotein antibody-negative acute disseminated encephalomyelitis18
Quality of life in young adolescents with epilepsy: A case control study18
The added value of multimodal neurophysiological tools in the prognostic assessment of perinatal hypoxic-ischemic encephalopathy16
Comparison of clinical characteristics between cluster and isolated seizures associated with benign convulsions with mild gastroenteritis16
“Fidgety-like movements” in extremely preterm infants - A new entity of spontaneous movements16
Identification of novel pathogenic variants in the GCDH gene and assessment of neurodevelopmental outcomes in 24 children with glutaric aciduria type 116
The development of checklists and reference charts for activities of daily living of normal developing children15
Acute seizures and the risk of post-stroke epilepsy in children with arterial ischemic stroke15
Genetic causes of infection induced encephalitis15
Dysmature patterns of newborn EEG recordings: Biological markers of transitory brain dysfunction or brain injury15
From childhood to adulthood: Long-term assessment of continuous intrathecal baclofen therapy in non-ambulant spastic cerebral palsy15
Unmet health care needs over the first 2 years after pediatric traumatic brain injury15
CSF IL-6 in children with neuroinflammatory conditions14
Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children14
Migraine and epilepsy: Social cognition skills in pediatric population13
Outcome measurement instruments in Rett syndrome: A systematic review13
Developmental neurobiology of cerebellar and Basal Ganglia connections13
Opioid analgesia and temperature regulation are associated with EEG background activity and MRI outcomes in neonates with mild-to-moderate hypoxic-ischemic encephalopathy undergoing therapeutic hypoth13
Assessing communication, beyond just words13
Behavioral problems in infants and young children with spinal muscular atrophy and their siblings: A cross-sectional study13
Fatigue, depression, and health-related quality of life in pediatric-onset multiple sclerosis: A comparative study from a tertiary care center12
Gene therapy offers promise, but timing is crucial for SMA treatment12
Seizures in children and adolescents with high-grade glioma: a retrospective, monocentric analysis12
Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders12
Bilateral frontal periventricular nodular heterotopia: a distinctive cortical malformation12
Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study12
Cost-effective diagnosis for children with developmental and epileptic encephalopathy phenotype12
GLUT1DS focus on dysarthria12
Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases11
Tumefactive demyelinating lesions: navigating the many faces of mimicry11
Letter to the Editor in response to Dr. Josef Finsterer et al. “Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants”11
Plant-derived cannabinoids for treatment of spasticity in children and adolescents with severe cerebral palsy: Double-blind, placebo-controlled trial11
Pediatric Neurotuberculosis: A cases series and review of the literature11
Dystonia during hand activity in children with spastic unilateral cerebral palsy, an observational study11
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes10
Exploring the connections between basal ganglia and cortex revealed by transcranial magnetic stimulation, evoked potential and deep brain stimulation in dystonia10
Experience of nusinersen treatment in advanced spinal muscular atrophy type 1: Characteristics of late responders with delayed treatment efficacy10
Piloting positive psychology resources for caregivers of a child with a genetic developmental and epileptic encephalopathy10
CSF-profile and hypocretin levels in children with narcolepsy type 1 and 210
Genotype variability in early-onset Hereditary Spastic Paraplegia: a single-center study10
The association of serum vitamin D concentrations in paediatric migraine10
Sphenoid dysplasia in patients with neurofibromatosis type 1: Clinical features and imaging findings including cerebrospinal fluid alterations10
Genotype – phenotype correlation of Spinal Muscular Atrophy in the era of disease modifying therapies: A tertiary Indian experience10
Vertigo, pediatric migraine, and best treatment9
Folker Hanefeld, 1937–20229
Health-related quality of life in 153 children with neuromuscular disorders in Latin America: is it age, functional dependence or diagnosis?9
Fat embolism syndrome in Duchenne muscular dystrophy: Report on a novel case and systematic literature review9
Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational study9
Editorial Board9
Temporal trends in intraventricular hemorrhage in preterm infants: A Brazilian multicenter cohort9
Prognostic significance of ACTN3 genotype in Duchenne muscular dystrophy: Findings from an Argentine patient cohort9
Frequency of an intrathecal IgM synthesis and MRZ reaction in children with MS9
It's easier to relearn gross motor skills than learn them for the first time after injury: Empirical evidence informing the age at injury debate9
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management9
The promise of personalized medicine in pediatric epilepsy – The time has come9
Behavioral, neurodevelopmental profile, and epilepsy trajectory in two series of SLC6A1-NDD: A retrospective study with comprehensive assessment, and a participatory database study9
Reevaluating isolated central apnea in early-term and term newborns: A neurological red flag for perinatal stroke8
Provoked seizures might lead to a significant diagnosis delay in CLN28
Pathological gait in Rett syndrome: Quantitative evaluation using three-dimensional gait analysis8
Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic rev8
Similar disease progression in nonsense Duchenne muscular dystrophy boys as general natural history: Single Brazilian center 15 years registry view8
Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants8
Determinants of long-term health-related quality of life in paediatric traumatic brain injury8
Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution8
The choroid plexus as a diagnostic tool in Sturge-Weber syndrome8
Limb girdle muscular dystrophies: striving to bridge a diagnostic gap8
Movement disorders, cerebral palsy and vaccination8
Reliability and validity of a newly developed PANDAS/PANS questionnaire8
Neuro-developmental outcomes in infants with vitamin B12-deficiency and neurologic features7
Autonomic risks in Alternating Hemiplegia of Childhood7
Long-term monitoring of children with Pseudo Tumor Cerebri Syndrome by transbulbar sonography7
Deep brain stimulation for phantom limb pain7
Is ketogenic diet a ‘precision medicine’? Recent developments and future challenges7
Are atypical knee jerk responses prognostic for cerebral palsy in high-risk infants and children?7
Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome7
Ocrelizumab in pediatric patients with MS: Efficacy, tolerability, and safety7
Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)7
Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec7
Predicting respiratory failure and outcome in pediatric Guillain-Barré syndrome7
Vaccination and childhood epilepsies7
Neurologic manifestations in children with COVID-197
Neurophysiological recordings improve the accuracy of the evaluation of the outcome in perinatal hypoxic ischemic encephalopathy7
Clinical and radiological findings of posterior reversible encephalopathy syndrome in children: About 16 children hospitalized in the pediatric department of a Tunisian tertiary care hospital7
Melatonin usage in children and young adults, a registry-based cohort study6
The use of intrathecal baclofen for management of spasticity in hereditary spastic paraparesis: A case series6
Reduced elbow muscle strength in children and adolescents with Charcot-Marie-Tooth disease: a case control study6
Time to reconsider the complex febrile seizure entity6
Advances in genetics: The start of a new stage for management of focal cortical malformations6
Harmful metabolic acidosis in children treated by ketogenic diet during prolonged general anesthesia for epilepsy surgery: A single center experience6
Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital6
Identification of PMD subgroups using a myelination score for PMD6
Room to improve: The diagnostic journey of Spinal Muscular Atrophy6
Cognitive development after perinatal unilateral infarctions: No evidence for preferential sparing of verbal functions6
“Deconstructing” upper limb function in dyskinetic cerebral palsy6
Deepening the understanding of mechanisms of antiepileptic effects of the ketogenic diet in children with AFG2A-related encephalopathy6
Bradykinesia assessment in children with cerebral palsy and periventricular leukomalacia6
Neurological and psychiatric phenotype of a multicenter cohort of patients with SETD5-related neurodevelopmental disorder6
Starting a DBS service for children: It’s not the latitude but the attitude - Establishment of the paediatric DBS centre in Northern Finland6
Optimising patient care, expectations and experiences: Healthcare providers’ experiences of delivering sleep medicine services within an Australian tertiary paediatric facility6
Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data6
Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases6
Outcome of herpes simplex virus encephalitis in children and young people5
Reassuring neuropsychological outcome data in myelin oligodendrocyte glycoprotein antibody-associated disease5
Approach to childhood tremors: Insights from a pediatric neurologist5
Lesion size and long-term cognitive outcome after pediatric stroke: A comparison between two techniques to assess lesion size5
Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials5
Developmental and epileptic encephalopathy 56 due to YWHAG variants: 12 new cases and review of the literature5
Pediatric-onset multiple sclerosis in Greece: A single-center study of the risk factors and a review of the literature5
Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial5
Effects of motor imagery adding to physiotherapy and rehabilitation program in children with Duchenne Muscular Dystrophy: does it make a difference?5
Transcranial magnetic stimulation in children with fetal alcohol spectrum disorder: A randomised, crossover pilot-trial5
Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature5
Impact of lesion metrics and neurological functions on long-term cognitive outcome in childhood stroke5
Brain morphometry and psychomotor development in children with PCH2A5
Pediatric vestibular migraine: Diagnosis according to ICHD-3 criteria and the effectiveness of short-term CH prophylaxis5
Unravelling key pathways in childhood ataxia to guide diagnosis and treatment5
Corrigendum to “Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen”[ Eur. J. Paediatr. Neurol. (2021) 92–105
Mitochondrial encephalopathies and myopathies: Our tertiary center's experience5
Education and participation in children and adolescents with Duchenne muscular dystrophy in Switzerland5
Dystonia following acquired brain injury (ABI) in childhood – Not as common as we might think?5
Phenotypic expansion of EGP5-related Vici syndrome: 15 Dutch patients carrying a founder variant5
Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases5
Efficacy and safety of Nusinersen among children with spinal muscular atrophy from North India: A prospective cohort study (NICE-SMA study)5
Editorial Board5
Deep Brain Stimulation in childhood-onset dystonia due to brain pathology. A long-term study5
0.081413984298706